Upgrade to SI Premium - Free Trial

RedHill Biopharma (RDHL)

1.03 +0.03 (3.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (6/8/26)

Latest Headlines

RedHill explores opaganib for ebola outbreak response June 2, 2026 8:00 AM - StreetInsider RedHill Biopharma Advancing Opaganib Options for Novel Dual Host Directed and Direct Acting Antiviral Approach for Ebola Outbreak Biodefense Platforms June 2, 2026 8:00 AM - PR NewsWire RedHill's RHB-204 shows comparable efficacy to RHB-104 in lab tests April 30, 2026 7:03 AM - StreetInsider RedHill's RHB-204 Demonstrates Comparable MAP Killing Efficacy to RHB-104 - Important Step in RHB-204 Development for MAP-related Crohn's Disease April 30, 2026 7:00 AM - PR NewsWire RedHill Biopharma Announces Full-Year 2025 Financial Results and Operational Highlights April 27, 2026 8:00 AM - PR NewsWire RedHill's Opaganib Enhances Efficacy of Neuroblastoma Chemo Combination and Augment Anti-Tumor Immunity in Triple-Negative Breast Cancer in Preclinical Studies - New Data Presented at AACR 2026 April 22, 2026 8:01 AM - PR NewsWire Full Article List